Thymectomy may ease neurological symptoms in older patients: Study
Surgical removal of the thymus, called a thymectomy, may significantly ease the neurological symptoms of patients older than 65…
Andrea Lobo is a Science writer at Bionews since 2022. She holds a PhD in Cell Biology/Neurosciences, where she studied the molecular pathways that contribute to neurodegeneration/neuroprotection in stroke biology. Between 2011 and 2021, she worked as a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, focused on the molecular mechanisms involved in drug addiction, particularly neuronal plasticity and remodeling induced by amphetamines. As a research scientist for 19 years, Andrea also participated in academic projects in other research fields, including gene regulation, cancer, and rare diseases. During her professional journey, Andrea also developed her science writing skills by writing/editing scientific papers and grant proposals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Surgical removal of the thymus, called a thymectomy, may significantly ease the neurological symptoms of patients older than 65…
UCB’s injection therapy Zilbrysq (zilucoplan) has gained approval in Canada for treating adults with generalized myasthenia gravis (gMG)…
Treatment with nipocalimab led to significant reductions in disease severity among people with generalized myasthenia gravis (gMG), as…
Treatment with Keytruda (pembrolizumab), an immune checkpoint inhibitor (ICI) used to treat cancer, may trigger myasthenia gravis (MG), according…
NMD Pharma announced the dosing of the first patient in a Phase 2b clinical trial of NMD670, its investigational…
A greater reduction in disease severity a month after surgery to remove the thymus gland in myasthenia gravis (MG)…
Blood levels of interleukin-41 (IL-41) — a signaling molecule involved in immune responses — are found to be significantly elevated…
The 2024 National Patient Conference by the Myasthenia Gravis Foundation of America (MGFA) brought together more than 400 members…
People with myasthenia gravis (MG) — particularly those with more severe symptoms — are significantly hindered both in their…
A young girl who showed unusual symptoms of ocular myasthenia gravis — persistent upper eyelid droopiness and outward deviation…
Get regular updates to your inbox.